GNH USA

Europe — EMA

Medi-Mibi (Technetium (99mtc) Sestamibi)

GNH USA supplies Medi-Mibi (Technetium (99mTc) Sestamibi), a radiopharmaceutical for myocardial perfusion and SPECT cardiac imaging.

Technetium (99mtc) Sestamibi

Request sourcing

1
Pack/s

What is Technetium (99mtc) Sestamibi?

Technetium (99mTc) Sestamibi, the active ingredient in Medi-Mibi, is a radiopharmaceutical presented as an injection for intravenous use. It is used to assess myocardial perfusion in adult patients undergoing cardiac imaging.

GNH USA supplies Medi-Mibi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

What is Technetium (99mtc) Sestamibi used for?

Medi-Mibi is employed in cardiac imaging to evaluate myocardial blood flow.

Myocardial perfusion imaging: enables visualization of regional blood flow to detect ischemia. SPECT imaging of the heart: provides high‑resolution images for assessment of coronary artery disease. Stress‑rest perfusion studies: allows comparison of perfusion under pharmacologic stress and at rest to identify reversible defects.

What are the side effects of Technetium (99mtc) Sestamibi?

Adverse reactions may occur following administration of Medi-Mibi.

Common Side Effects: - Nausea - Headache - Dizziness - Injection site discomfort

Serious or Rare Side Effects: - Anaphylactic reaction - Severe hypotension - Radiation‑induced skin injury

What precautions apply to Technetium (99mtc) Sestamibi?

Use of Medi-Mibi requires careful patient assessment and handling. - Allergy verification: confirm no known hypersensitivity to technetium‑based agents. - Hydration status: ensure adequate patient hydration to facilitate tracer clearance. - Renal function: avoid or adjust use in patients with severe renal impairment. - Pregnancy risk: assess benefit‑risk ratio before use in pregnant individuals. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Technetium (99mtc) Sestamibi interact with?

Medi-Mibi may interact with other agents that affect imaging or physiological responses.

Major Interactions (Avoid): - Concurrent radiopharmaceuticals that could interfere with image interpretation. - High‑dose iodinated contrast agents that may alter thyroid uptake of technetium.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt heart rate response during stress testing. - Calcium channel blockers: can modify myocardial perfusion patterns. - Thyroid hormone therapy: may affect background tracer distribution.

Frequently asked questions

What is Medi-Mibi used for?+
Medi-Mibi is a radiopharmaceutical used primarily for myocardial perfusion imaging and single‑photon emission computed tomography (SPECT) of the heart. It helps clinicians assess blood flow to cardiac tissue, identify areas of reduced perfusion, and evaluate coronary artery disease.
How does Technetium (99mTc) Sestamibi work?+
Technetium‑99m sestamibi is a lipophilic cation that enters myocardial cells proportionally to blood flow and binds to mitochondria. The technetium‑99m isotope emits gamma radiation, which is detected by SPECT cameras to create detailed images of myocardial perfusion.
What is the usual dose of Medi-Mibi?+
The prescribed dose of Medi-Mibi is determined by the ordering physician based on the specific imaging protocol, patient weight, and clinical indication. Dosing is individualized and should follow established nuclear medicine guidelines.
Is Medi-Mibi safe during pregnancy or breastfeeding?+
Safety data for Medi-Mibi in pregnancy and lactation are limited. It should only be used when the potential diagnostic benefit outweighs any possible risk to the fetus or infant, and after careful consideration by the treating physician.
How do I order Medi-Mibi from GNH USA?+
To order Medi-Mibi, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and necessary import documentation.
How does Medi-Mibi compare with the main alternative drug or class?+
The primary alternative for myocardial perfusion imaging is Thallium‑201. Compared with Thallium‑201, Technetium‑99m sestamibi offers higher photon energy, better image resolution, and a shorter half‑life, which reduces radiation exposure and allows for faster imaging protocols.
What are the storage and handling requirements for Medi-Mibi?+
Medi-Mibi must be stored refrigerated at 2‑8 °C, protected from light, and kept in its original container. Do not freeze or shake the vial, and use the product within the time frame specified by the manufacturer after removal from cold storage.
How is Medi-Mibi administered?+
Medi-Mibi is administered as an intravenous injection by qualified nuclear medicine personnel. The tracer is typically injected through a peripheral vein, and imaging is performed shortly after administration according to the prescribed protocol.
What are the most serious risks to watch for?+
Serious risks associated with Medi-Mibi include anaphylactic reactions, severe hypotension, and radiation‑induced skin injury. Immediate medical attention is required if any signs of severe allergic response, sudden drop in blood pressure, or unexpected skin changes occur after injection.
Who should not use Medi-Mibi?+
Medi-Mibi should be avoided in patients with known hypersensitivity to technetium‑based agents, those with severe renal impairment, and pregnant women unless the diagnostic benefit justifies the potential risk. The prescribing clinician must evaluate each patient’s suitability before administration.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Technetium (99mtc) Sestamibi
Route
Intravenous Use
Manufacturer
Radiopharmacy Laboratórium Kft.
Origin
EU

Related products

Cardio-Spect

Cardio-Spect

Technetium (99mtc) Sestamibi

Medi-Radiopharma Kft.
EU
Medi-Mibi

Medi-Mibi

Technetium (99mtc) Sestamibi

Radiopharmacy Laboratórium Kft.
EU
Medi-Mibi

Medi-Mibi

Technetium (99mtc) Sestamibi

Medi-Radiopharma Kft.
EU
Medi-Mibi

Medi-Mibi

Technetium (99mtc) Sestamibi

Radiopharmacy Laboratórium Kft.
EU